Sun Pharma

NIPERs and Pharma Industries bridged to fulfill academic and industry gap

  • Posted on: 6 November 2015
  • By: admin

National Institutes for Pharmaceutical Education and Research (NIPERs) and Pharma Industries signed 17 MoU to bridge gap betwwen academic education and industrial needs. One of the critical factors in building innovation ecosystem and for Drug Discovery is Academia-Industry linkage. Department of Pharmaceuticals (DoP) for the last one year has actively engaged both the NIPERs and the Pharma Industry to build partnership in areas of education, research and development.

Opening to work as Business Development Executive in Sun Pharma

Sun Pharma ranks amongst India's largest pharma companies We’ve built a reputation for speciality therapy leadership and faster- than-industry growth over the last 30 years. From a modest beginning with five people, our team today exceeds 13,000 and growing, put manufacturing base now spans 25 sites across the world. With a market cap of over $ 16 billion, we’re also India’s most valued pharma brand. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Halol (Near Baroda):

Post: Business Development Executive

Sun Pharma settles patent litigation with Actavis Group

  • Posted on: 9 October 2015
  • By: Shalini.Sharma

Sun Pharmaceutical Industries announced that Ranbaxy Pharmaceuticals Inc. (Ranbaxy), a wholly-owned subsidiary, along with its partners, Cipher Pharmaceuticals Inc. (Cipher) and Galephar Pharmaceutical Research, Inc. (Galephar) have entered into a settlement agreement with Actavis Group (Actavis) that dismisses the patent litigation suit relating to Actavis’ Abbreviated New Drug Application (ANDA) for a generic version of Absorica (isotretinoin capsules). Absorica is the registered trademark of Ranbaxy Laboratories Inc.

Career as Assistant Product Manager/Product Manager - Anti Infective / Antibiotics in Sun Pharma

Sun Pharma ranks amongst India's largest pharma companies We’ve built a reputation for speciality therapy leadership and faster- than-industry growth over the last 30 years. From a modest beginning with five people, our team today exceeds 13,000 and growing, put manufacturing base now spans 25 sites across the world. With a market cap of over $ 16 billion, we’re also India’s most valued pharma brand. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Halol (Near Baroda):

Post: Assistant Product Manager/Product Manager - Anti Infective / Antibiotics

Sun Pharma and Wockhardt recall their drugs from US market

  • Posted on: 4 September 2015
  • By: Shalini.Sharma

Voluntary recall of a number of drugs have been initiated by Sun Pharma and Wockhardt from the US market due to different reasons.

Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-release Tablets USP (SR), 200 mg, 60-count bottle for "failed dissolution specification", while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg for "CGMP violations".

Opening for Officer /Executive – Analytical Development in Sun Pharma

Sun Pharma ranks amongst India's largest pharma companies We’ve built a reputation for speciality therapy leadership and faster- than-industry growth over the last 30 years. From a modest beginning with five people, our team today exceeds 13,000 and growing, put manufacturing base now spans 25 sites across the world. With a market cap of over $ 16 billion, we’re also India’s most valued pharma brand. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Halol (Near Baroda):

Post: Officer /Executive – Analytical Development (11123)

USFDA reject approval of Sun Pharma’s novel anti-glaucoma eye drops

  • Posted on: 4 August 2015
  • By: Shalini.Sharma

USFDA rejected Sun Pharma Advanced Research Company’s Application for its new anti-glaucoma eye drops. The product is to be manufactured at Sun Pharmaceutical Industries’ Halol facility. USFDA has indicated that a satisfactory resolution of the current good manufacturing practice (cGMP) deficiencies at this facility is a prerequisite for the final approval of Xelpros.

Vacancy as Officer / Executive – Formulation Development in Sun Pharma

Sun Pharma ranks amongst India's largest pharma companies We’ve built a reputation for speciality therapy leadership and faster- than-industry growth over the last 30 years. From a modest beginning with five people, our team today exceeds 13,000 and growing, put manufacturing base now spans 25 sites across the world. With a market cap of over $ 16 billion, we’re also India’s most valued pharma brand. To keep pace with our growth plans, we require for our Formulation manufacturing plant at Halol (Near Baroda):

Post: Officer / Executive – Formulation Development

Pages